IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,421 | -99.9% | 1,330,102 | +22.4% | 0.35% | +76.1% |
| Q3 2022 | $10,767,000 | +115.3% | 1,086,501 | +113.1% | 0.20% | +58.9% |
| Q2 2022 | $5,002,000 | +185.7% | 509,934 | +185.7% | 0.12% | +153.1% |
| Q1 2022 | $1,751,000 | -3.3% | 178,495 | -4.6% | 0.05% | +11.4% |
| Q4 2021 | $1,811,000 | +1658.3% | 187,117 | +1667.3% | 0.04% | +2100.0% |
| Q3 2021 | $103,000 | -3.7% | 10,588 | -4.5% | 0.00% | 0.0% |
| Q2 2021 | $107,000 | – | 11,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |